Northern Trust
BEAM icon

Northern Trust’s Beam Therapeutics BEAM Stock Holding History

Northern Trust’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32M Buy
933,481
+107,901
+13% +$3.26M ﹤0.01% 1506
2026
Q1 		$19.7M Buy
825,580
+16,633
+2% +$462K ﹤0.01% 1690
2025
Q4 		$22.4M Sell
808,947
-45,397
-5% -$1.16M ﹤0.01% 1590
2025
Q3 		$20.7M Buy
854,344
+25,836
+3% +$514K ﹤0.01% 1658
2025
Q2 		$14.1M Sell
828,508
-25,041
-3% -$436K ﹤0.01% 1867
2025
Q1 		$16.7M Buy
853,549
+113,043
+15% +$2.96M ﹤0.01% 1738
2024
Q4 		$18.4M Buy
740,506
+49,415
+7% +$1.26M ﹤0.01% 1746
2024
Q3 		$16.9M Buy
691,091
+33,709
+5% +$871K ﹤0.01% 1728
2024
Q2 		$15.4M Sell
657,382
-1,798
-0.3% -$44.2K ﹤0.01% 1721
2024
Q1 		$21.8M Sell
659,180
-9,362
-1% -$292K ﹤0.01% 1535
2023
Q4 		$18.2M Buy
668,542
+13,934
+2% +$346K ﹤0.01% 1678
2023
Q3 		$15.7M Buy
654,608
+29,646
+5% +$795K ﹤0.01% 1710
2023
Q2 		$20M Buy
624,962
+16,998
+3% +$552K ﹤0.01% 1585
2023
Q1 		$18.6M Sell
607,964
-4,886
-0.8% -$193K ﹤0.01% 1604
2022
Q4 		$24M Buy
612,850
+8,410
+1% +$377K 0.01% 1414
2022
Q3 		$28.8M Buy
604,440
+42,337
+8% +$2.42M 0.01% 1218
2022
Q2 		$21.8M Buy
562,103
+101,060
+22% +$4.02M ﹤0.01% 1466
2022
Q1 		$26.4M Sell
461,043
-18,915
-4% -$1.24M ﹤0.01% 1477
2021
Q4 		$38.2M Buy
479,958
+1,061
+0.2% +$90.8K 0.01% 1299
2021
Q3 		$41.7M Buy
478,897
+25,323
+6% +$2.54M 0.01% 1230
2021
Q2 		$58.4M Buy
453,574
+50,817
+13% +$4.05M 0.01% 1008
2021
Q1 		$32.2M Sell
402,757
-24,400
-6% -$2.32M 0.01% 1483
2020
Q4 		$34.9M Buy
427,157
+45,101
+12% +$2.22M 0.01% 1375
2020
Q3 		$9.41M Buy
382,056
+214,813
+128% +$5.33M ﹤0.01% 2145
2020
Q2 		$4.68M Buy
167,243
+36,217
+28% +$780K ﹤0.01% 2568
2020
Q1 		$2.36M Buy
+131,026
New +$2.85M ﹤0.01% 2763

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Northern Trust's BEAM Position: Q2 2026 in Review

Northern Trust increased its Beam Therapeutics (BEAM) stake by 13% in Q2 2026, buying an estimated $3.26M and bringing the position to 933,481 shares worth $32M. The position accounts for ﹤0.01% of the portfolio, ranked #1506.

Northern Trust first reported a position in BEAM in Q1 2020 and has held it in 26 quarters since. The position peaked at $58.4M in Q2 2021. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Northern Trust held 933,481 shares of Beam Therapeutics worth $32M as of Q2 2026.
  • Northern Trust bought 107,901 Beam Therapeutics shares in Q2 2026, an estimated $3.26M.
  • Beam Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1506 holding.
  • Northern Trust first reported a position in Beam Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Northern Trust's Beam Therapeutics position peaked at $58.4M in Q2 2021.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.